Pancreas, Liver and Shunt Procedures with CC DRG Reimbursement

Perioperative intervention trials assessing techniques to reduce perioperative morbidity and shorten length of stay after complex pancreatic or hepatic resections: these studies enroll adults undergoing pancreaticoduodenectomy, distal pancreatectomy, hepatic resection, or surgical shunt procedures and compare specific intraoperative strategies (for example enhanced hemostasis protocols, anesthesia approaches, or prophylactic measures against pancreatic fistula and bile leak). The objective is to reduce postoperative complications such as hemorrhage, pancreatic fistula, biliary leak, and sepsis that drive CC-level resource use; results are directly relevant to surgeons, hospital quality teams, and payers because improved protocols can lower ICU utilization and readmissions. - Comparative effectiveness studies of surgical versus endovascular or minimally invasive approaches for portal hypertension and liver-related shunt procedures: these trials examine populations with portal hypertension, variceal bleeding risk, or refractory ascites who are candidates for surgical shunts, transjugular intrahepatic portosystemic shunt alternatives, or hybrid approaches, comparing outcomes like rebleeding, hepatic encephalopathy, and overall resource utilization. The goal is to define which approach yields the best balance of durable clinical benefit and lower downstream costs in patients with significant comorbidity; findings inform procedural selection, discharge planning, and payer decisions about coverage and expected postprocedural care needs. - Post-discharge outcomes and care coordination studies focused on readmission reduction and long-term functional recovery after complex pancreas and liver surgeries: these observational cohorts or interventional care-model trials follow patients after discharge to evaluate multimodal rehabilitation, nutrition support, outpatient surveillance strategies, and early complication detection in patients with postoperative complications or who required intensive inpatient resources. By targeting high-risk patients who incurred CC-level complications, this research identifies interventions that reduce 30- and 90-day readmissions, emergency department visits, and prolonged outpatient resource use, outcomes that matter to hospitals and payers aiming to improve quality metrics and control post-acute spending.

Perioperative intervention trials assessing techniques to reduce perioperative morbidity and shorten length of stay after complex pancreatic or hepatic resections: these studies enroll adults undergoing pancreaticoduodenectomy, distal pancreatectomy, hepatic resection, or surgical shunt procedures and compare specific intraoperative strategies (for example enhanced hemostasis protocols, anesthesia approaches, or prophylactic measures against pancreatic fistula and bile leak). The objective is to reduce postoperative complications such as hemorrhage, pancreatic fistula, biliary leak, and sepsis that drive CC-level resource use; results are directly relevant to surgeons, hospital quality teams, and payers because improved protocols can lower ICU utilization and readmissions. - Comparative effectiveness studies of surgical versus endovascular or minimally invasive approaches for portal hypertension and liver-related shunt procedures: these trials examine populations with portal hypertension, variceal bleeding risk, or refractory ascites who are candidates for surgical shunts, transjugular intrahepatic portosystemic shunt alternatives, or hybrid approaches, comparing outcomes like rebleeding, hepatic encephalopathy, and overall resource utilization. The goal is to define which approach yields the best balance of durable clinical benefit and lower downstream costs in patients with significant comorbidity; findings inform procedural selection, discharge planning, and payer decisions about coverage and expected postprocedural care needs. - Post-discharge outcomes and care coordination studies focused on readmission reduction and long-term functional recovery after complex pancreas and liver surgeries: these observational cohorts or interventional care-model trials follow patients after discharge to evaluate multimodal rehabilitation, nutrition support, outpatient surveillance strategies, and early complication detection in patients with postoperative complications or who required intensive inpatient resources. By targeting high-risk patients who incurred CC-level complications, this research identifies interventions that reduce 30- and 90-day readmissions, emergency department visits, and prolonged outpatient resource use, outcomes that matter to hospitals and payers aiming to improve quality metrics and control post-acute spending.

OpenPayer

Summary & Overview

Pancreas, Liver and Shunt Procedures with CC: Inpatient Reimbursement Overview

DRG 406 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes